Listed

Mesa Laboratories Inc: Form 10-Q for the period ended Dec 31, 2016

Filed with the SEC on Feb 6, 2017 and accepted by EDGAR at Feb 6, 2017, 08:03 ET.

Share

Sections

The sections of this filing are being extracted from EDGAR and appear here in about a minute. Meanwhile, read the original on sec.gov. The main document on sec.gov.

Figures reported in this filing

Standardized line items from the XBRL in this filing, for the period ended 2016-12-31. Comparative periods it repeats are left out.

Figures reported in this filing
Line itemPeriodValueXBRL concept
Revenue9 months2016-04-01 to 2016-12-31$69.4mus-gaap:SalesRevenueNet
Cost of revenue3 months2016-10-01 to 2016-12-31$10.3mus-gaap:CostOfRevenue
Cost of revenue9 months2016-04-01 to 2016-12-31$30.1mus-gaap:CostOfRevenue
Gross profit3 months2016-10-01 to 2016-12-31$13.5mus-gaap:GrossProfit
Gross profit9 months2016-04-01 to 2016-12-31$39.3mus-gaap:GrossProfit
Research and development3 months2016-10-01 to 2016-12-31$861.0kus-gaap:ResearchAndDevelopmentExpense
Research and development9 months2016-04-01 to 2016-12-31$2.9mus-gaap:ResearchAndDevelopmentExpense
Operating income3 months2016-10-01 to 2016-12-31$4.4mus-gaap:OperatingIncomeLoss
Operating income9 months2016-04-01 to 2016-12-31$11.0mus-gaap:OperatingIncomeLoss
Income tax3 months2016-10-01 to 2016-12-31$628.0kus-gaap:IncomeTaxExpenseBenefit
Income tax9 months2016-04-01 to 2016-12-31$1.7mus-gaap:IncomeTaxExpenseBenefit
Net income3 months2016-10-01 to 2016-12-31$3.3mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Net income9 months2016-04-01 to 2016-12-31$7.5mus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Diluted EPS3 months2016-10-01 to 2016-12-31$0.84us-gaap:EarningsPerShareDiluted
Diluted EPS9 months2016-04-01 to 2016-12-31$1.97us-gaap:EarningsPerShareDiluted
Basic EPS3 months2016-10-01 to 2016-12-31$0.88us-gaap:EarningsPerShareBasic
Basic EPS9 months2016-04-01 to 2016-12-31$2.06us-gaap:EarningsPerShareBasic
Diluted shares (weighted)3 months2016-10-01 to 2016-12-313,868,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Diluted shares (weighted)9 months2016-04-01 to 2016-12-313,835,000 sharesus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Dividends paid9 months2016-04-01 to 2016-12-31$1.8mus-gaap:PaymentsOfDividends
Cash and equivalentsAt period end2016-12-31$5.4mus-gaap:CashAndCashEquivalentsAtCarryingValue
Current assetsAt period end2016-12-31$35.0mus-gaap:AssetsCurrent
Total assetsAt period end2016-12-31$170.5mus-gaap:Assets
Current liabilitiesAt period end2016-12-31$22.0mus-gaap:LiabilitiesCurrent
Total liabilitiesAt period end2016-12-31$76.7mus-gaap:Liabilities
Long-term debtAt period end2016-12-31$50.0mus-gaap:LongTermDebtNoncurrent
Current portion of debtAt period end2016-12-31$3.0mus-gaap:LongTermDebtCurrent
Shareholders' equityAt period end2016-12-31$93.7mus-gaap:StockholdersEquity

Source: SEC EDGAR, the filing index for accession 0001437749-17-001685. Last ingested by Listed: Nov 13, 2026, 07:45 ET. Listed shows no prices and gives no investment advice.